| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
See Remarks | Chief Commercial Officer
1 company
Maduck Sean serves as a See Remarks at CORT. Across recent SEC filings that breaks down to 0 buys and 70 sells. Those positions are worth an estimated $286K at current prices.
Historically, Maduck Sean's trades have earned a middling insider score of 52/100 across 40 rated trades. Over a 12-month horizon, 29.4% of those trades were profitable, with an average 12-month return of -28.0%.
The biggest single holding is CORT (~$286K) as See Remarks. The recent filings there lean toward selling, a net 1,044,169 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 2, 2026 | CORT Corcept Therapeutics Incorporated | See Remarks | Sale+OE | 25,000 | $116.26 | $2,906,601.28 | -71.6% | - | - | |
| Sep 1, 2026 | CORT Corcept Therapeutics Incorporated | See Remarks | Sale+OE | 25,000 | $114.43 | $2,860,737.21 | -71.9% | - | - | |
| Aug 25, 2026 | CORT Corcept Therapeutics Incorporated | See Remarks | Sale+OE | 30,955 | $125.58 | $3,887,319.90 | -76.0% | - | - | |
| Aug 14, 2026 | CORT Corcept Therapeutics Incorporated | See Remarks | Sale+OE | 3,664 | $114.49 | $419,491.36 | -27.3% | - | - | |
| Aug 10, 2026 | CORT Corcept Therapeutics Incorporated | See Remarks | Sale+OE | 1,031 | $114.52 | $118,068.26 | -9.6% | - | - | |
| Aug 3, 2026 | CORT Corcept Therapeutics Incorporated | See Remarks | Sale+OE | 20,305 | $114.70 | $2,329,074.87 | -67.5% | - | - | |
| Jul 1, 2026 | CORT Corcept Therapeutics Incorporated | See Remarks | Sale+OE | 25,000 | $88.35 | $2,208,736.56 | -71.9% | - | - | |
| May 27, 2026 | CORT Corcept Therapeutics Incorporated | See Remarks | Sale+OE | 75,000 | $65.59 | $4,918,943.74 | -89.3% | - | - | |
| Dec 1, 2025 | CORT Corcept Therapeutics Inc | See Remarks | Sale+OE | 20,000 | $79.52 | $1,590,490.00 | -71.7% | -54.9% | - | |
| Nov 3, 2025 | CORT Corcept Therapeutics Inc | See Remarks | Sale+OE | 20,000 | $73.99 | $1,479,816.00 | -71.7% | -45.1% | - |